TW
Twist Bioscience
TWST · NASDAQ
$165.81 +0.04% (+$0.07)
1M +17.78%
Market Cap $10.3B
P/E Ratio -
Div. Yield -
ROE 29.89%
Bulios Fair Price
$122.25
26.3% downside
Current Price
$165.81
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TWST is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 23.16x
P/S 23.91x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 15.70%
Rev. growth 22.76%
FCF growth N/A
Profitability
20 /100
Weak Net margin 31.66%
Op. margin 31.91%
FCF margin 21.57%
Quality
8 /100
Poor ROE 29.89%
ROA 20.33%
Asset turnover 0.64x
Debt
100 /100
Low Current ratio 2.67x
Debt/Equity 0.21x
Net debt/EBITDA N/A
Stability
49 /100
Moderate Rev. volatility 4.23%
EPS volatility 34.18%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TWST
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Emily Marine Leproust
Employees
979
Headquarters
South San Francisco
Upcoming events
13 NOV
Earnings
Upcoming earnings report